OXA-143

........10........20........30........40........50........60........70........80........90.......100.......110.......120.......130.......140.......150.......160.......170.......180.......190.......200.......210.......220.......230.......240.......250.......260.......270..... MKKFILPILSISTLLSVSACSSIQTKFEDTFHTSNQQHEKAIKSYFDEAQTQGVIIIKKGKNISTYGNNLTRAHTEYVPASTFKMLNALIGLENHKATTTEIFKWDGKKRSYPMWEKDMTLGDAMALSAVPVYQELARRTGLDLMQKEVKRVGFGNMNIGTQVDNFWLVGPLKITPIQEVNFADDFANNRLPFKLETQEEVKKMLLIKEFNGSKIYAKSGWGMDVTPQVGWLTGWVEKSNGEKVAFSLNIEMKQGMPGSIRNEITYKSLENLGII

OXA-182	........F...I...L...............I...K.....................E.....S.....V............................N......................E...........D....I..N.........................I................L.......................V...............S..................S...........S..................	93.09 %
OXA-231	...............................................................................................................................................................................................................................A...................................................	99.64 %
OXA-253	........F...I...L.............SDI.D..QG...................E...........A..................................................................................................................L.......................V...............I..................P....L......S..................	93.82 %
OXA-255	........F.......L....T..N...K.SDI.D.......................E....RI.....V......................................................................................S.....N...............A.....L.......................V..................................P....L......S..................	92.36 %
OXA-499	........F.......L.......N...N.SDI.D.......................E....RI.....V............................................................................................N...............A.....L.......................V..................................P....L......S..................	93.09 %
OXA-649	........F...I...L.......N...Y.SDI.D...G...................E...........A..................................................................................................................L.......................V..................................P....L......S..................	93.82 %
OXA-825	........F.......L....T..N...K.SDI.D.......................E....RI.....V..........................................I.................................................N...............A..V..L.......................V..................................P....L......S..................	92.00 %
OXA-945	........F.......L.................D....................V..E...........A............................A.....................................................................................L.............K.R.......V..................................P....L......S..................	94.91 %
OXA-1139	........F.......L....T..N...N.SDI.D.......................E....RI.....V............................................................................................N...............A.....L.......................V..................................P....L......S..................	92.73 %
OXA-1182	........F.......L.................D.......................E.....I.....A...........................K.......................E.....................................I........................L.......................V...............S..................P....L......S..................	94.55 %

Last updated: January 08, 2024.

If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.

The development of the BLDB database is funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).

Contact: contact@bldb.eu

Live statistics (since December 3rd, 2023)